1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Generic Name | Common Trade Name(s) | Classification | Date Marketed in Canada (yyyy/mm/dd) |
---|---|---|---|
Tolvaptan | Jinarc | Vasopressin V2-receptor antagonist | 2015/06/01 |
Aclidinium + formoterol | Duaklir Genuair | Bronchodilator combination - LAMA plus LABA | 2015/07/09 |
Vilazodone | Viibryd | Antidepressant | 2015/07/16 |
Polidocanol | Varithena | Sclerosing agent | 2015/08/04 |
Empagliflozin | Jardiance | Sodium-glucose contransporter 2 (SGLT2) inhibitor | 2015/08/11 |
Naloxegol | Movantik | Miscellaneous GI drug | 2015/08/27 |
Ulipristal acetate | Ella | Contraceptive | 2015/09/01 |
Daclatasvir | Daklinza | Antiviral agent | 2015/09/08 |
Tedizolid | Sivextro | Oxazolidinone antibiotic | 2015/10/08 |
Azelastine + fluticasone | Dymista | Antihistamine and corticosteroid agent | 2015/10/22 |
Sacubitril + valsartan | Entresto | Endopeptidase inhibitor, angiotension II receptor antagonist | 2015/11/13 |
Dulaglutide | Trulicity | Antihyperglycemic agent | 2016/01/08 |
Levonorgestrel | Backup Plan Onestep | Contraceptive agent | 2016/01/28 |
Elbasvir + grazoprevir | Zepatier | Antiviral agent | 2016/02/02 |
Elvitegravir + cobicistat + emtricitabine + tenofovir alafenamide | Genvoya | Antiretroviral agents | 2016/02/03 |
Dapgliflozin + metformin | Xigduo | Sodium-glucose contransporter 2 (SGLT2) inhibitor plus metformin | 2016/02/08 |
Dapgliflozin | Forxiga | Sodium-glucose contransporter 2 (SGLT2) inhibitor | 2016/02/10 |
Exenatide | Bydureon | Incretin mimetic | 2016/02/16 |
Albiglutide | Eperzan | Antihyperglycemic agent | 2016/02/19 |
Betamethasone valerate | Beteflam | Anti-inflammatory agent | 2016/04/05 |
Selexipag | Uptravi | Prostacyclin receptor antagonist | 2016/04/21 |
Asunaprevir | Sunvepra | Antiviral agent | 2016/04/22 |
Testosterone | Natesto | Androgen | 2016/05/06 |
Brivaracetam | Brivlera | Antiepileptic agent | 2016/05/10 |
Emtricitabine + tenofovir | Descovy | Antiretroviral agent | 2016/06/03 |
Sofosbuvir + velpatasvir | Epclusa | Antiviral agent | 2016/07/11 |
Ixazomib | Ninlaro | Antineoplastic agent | 2016/09/21 |
Levomilnacipran | Fetzima | Antidepressant | 2016/10/16 |
Mifepristone + misoprostol | Mifegymiso | Abortifacient | 2016/10/21 |
Venetoclax | Venclexta | Antineoplastic agent | 2016/10/31 |
Cefotaxime | Claforan | Cephalosporin antibiotic | 2016/11/09 |
Bilastine | Blexten | Antihistamine | 2016/12/02 |
Empagliflozin + linagliptin | Glyxambi | Antidiabetic agent | 2016/12/15 |
Edoxaban | Lixiana | Anticoagulant | 2017/01 |
Phosphate Effervescent | Phosphate Sandoz | 2017/01/01 | |
Rupatadine | Rupall | Antihistamine, second generation | 2017/01/25 |